1. Home
  2. NEOG vs PVLA Comparison

NEOG vs PVLA Comparison

Compare NEOG & PVLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Neogen Corporation

NEOG

Neogen Corporation

HOLD

Current Price

$11.87

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Logo Palvella Therapeutics Inc.

PVLA

Palvella Therapeutics Inc.

N/A

Current Price

$128.62

Market Cap

1.9B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NEOG
PVLA
Founded
1981
2015
Country
United States
United States
Employees
N/A
29
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
1.9B
IPO Year
1995
2013

Fundamental Metrics

Financial Performance
Metric
NEOG
PVLA
Price
$11.87
$128.62
Analyst Decision
Buy
Strong Buy
Analyst Count
4
15
Target Price
$14.00
★ $230.53
AVG Volume (30 Days)
★ 3.9M
164.9K
Earning Date
10-06-2026
11-10-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 99.20
52.62
EPS
★ N/A
N/A
Revenue
★ $870,400,000.00
$42,810,000.00
Revenue This Year
$1.47
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ 65.28
52 Week Low
$5.37
$65.93
52 Week High
$14.26
$161.38

Technical Indicators

Market Signals
Indicator
NEOG
PVLA
Relative Strength Index (RSI) 44.24 31.09
Support Level $8.68 $109.68
Resistance Level $12.55 $135.23
Average True Range (ATR) 0.71 6.38
MACD -0.16 -2.30
Stochastic Oscillator 1.90 14.11

Price Performance

Historical Comparison
NEOG
PVLA

About NEOG Neogen Corporation

Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety, the company performs diagnostics to detect unintended substances in food and animal feed, to prevent contamination and foodborne illnesses such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, and ruminant by-products. In animal safety, the company segment is engaged in the development, manufacture, marketing and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products and genomics testing services.

About PVLA Palvella Therapeutics Inc.

Palvella Therapeutics Inc is a clinical-stage biopharmaceutical company whose vision is to become the rare disease biopharmaceutical company focused on developing and commercializing novel therapies to treat patients suffering from serious, rare skin diseases and vascular malformations for which there are no FDA-approved therapies. Its product candidate, QTORIN 3.9% rapamycin anhydrous gel, is currently in clinical development for microcystic lymphatic malformations and cutaneous venous malformations. It operates in single segment.

Share on Social Networks: